Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation
PLOS Computational Biology · 2024
DOI: 10.1371/journal.pcbi.1012565 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Jørgen Ankill und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Genetics, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: DNA Methylation, Neoplasms, Gene Regulatory Networks, CpG Islands. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South-Eastern Norway Regional Health Authority, Helse Sør-Øst RHF.
Abstract (Originalsprache)
Aberrant DNA methylation contributes to gene expression deregulation in cancer. However, these alterations’ precise regulatory role and clinical implications are still not fully understood. In this study, we performed expression-methylation Quantitative Trait Loci (emQTL) analysis to identify deregulated cancer-driving transcriptional networks linked to CpG demethylation pan-cancer. By analyzing 33 cancer types from The Cancer Genome Atlas, we identified and confirmed significant correlations between CpG methylation and gene expression (emQTL) in cis and trans , both across and within cancer types. Bipartite network analysis of the emQTL revealed groups of CpGs and genes related to important biological processes involved in carcinogenesis including proliferation, metabolism and hormone-signaling. These bipartite communities were characterized by loss of enhancer methylation in specific transcription factor binding regions (TFBRs) and the CpGs were topologically linked to upregulated genes through chromatin loops. Penalized Cox regression analysis showed a significant prognostic impact of the pan-cancer emQTL in many cancer types. Taken together, our integrative pan-cancer analysis reveals a common architecture where hallmark cancer-driving functions are affected by the loss of enhancer methylation and may be epigenetically regulated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cancer Genetics, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Oslo Centre for Biostatistics and Epidemiology (OCBE), Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Medical Genetics, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.
- Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Norway, Oslo, Norway.
- Department of Pharmacy, University of Oslo, Oslo, Norway.
ORCID-Profile: Jørgen Ankill, Zhi Zhao, Anthony Mathelier, Thomas Fleischer
Förderung
- South-Eastern Norway Regional Health Authority
- Helse Sør-Øst RHF
Zitieren
APA
Ankill, J., Zhao, Z., Tekpli, X., Kure, E. H., Kristensen, V. N., Mathelier, A., & Fleischer, T. (2024). Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012565
Vancouver
Ankill J, Zhao Z, Tekpli X, Kure EH, Kristensen VN, Mathelier A, et al. Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012565
BibTeX
@article{Ankill2024,
author = {Ankill, Jørgen and Zhao, Zhi and Tekpli, Xavier and Kure, Elin H and Kristensen, Vessela N and Mathelier, Anthony and Fleischer, Thomas},
title = {Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation},
journal = {PLOS Computational Biology},
year = {2024},
doi = {10.1371/journal.pcbi.1012565}
}
EUVIMED